Member states backed Denmark’s push for DEHP to be identified in EU law as having endocrine disrupting properties for the environment, but did not agree to call it a human endocrine disruptor too.
The European Commission must decide whether DEHP, along with DBP, BBP and DiBP, should be identified as endocrine disrupting chemicals (EDCs) affecting human health.
The majority of member states agreed with Denmark that the four phthalates should be identified as human EDCs, but a minority argued that such a classification was not necessary, given the phthalates are already identified as ‘substances of very high concern’ under REACH due to their toxicity to reproduction.
Please enter your details
Not a subscriber?
Take a free trial now to discover the critical insights and updates our coverage offers subscribers.